The major Part D plan sponsors may have favored receiving drug rebates over drug price discounts in negotiations with pharmaceutical manufacturers for the 2006 benefit year, based on a recently released 1analysis by the Kaiser Family Foundation

The major Part D plan sponsors may have favored receiving drug rebates over drug price discounts in negotiations with pharmaceutical manufacturers for the 2006 benefit year, based on a recently released 1analysis by the Kaiser Family Foundation

Part D drug plan pharmacy & therapeutics committees must make coverage decisions about new drugs or new indications within 90 days of their entry into the market in Medicare's six "all or substantially all" therapeutic categories, the Centers for Medicare & Medicaid Services states in its final formulary review 1guidelines for the 2007 contract year